Gainers
$Bone Biologics(BBLG.US)$ rose 21.28% to $4.16 in pre-market trading.
$Molecular(MOLN.US)$ rose 17.08% to $19.33 in pre-market trading after the company and Novartis disclosed positive topline data from Phase 2 study for Ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19.
$OneSmart International Education(ONE.US)$ rose 16.34% to $0.337 in pre-market trading after gaining more than 5% on Friday.
$Pluristem Therapeutics(PSTI.US)$ rose 17.69% to $1.73 in pre-market trading after the company and and Israel's Largest Food Producer Tnuva, announced a landmark collaboration to establish cultured food platform.$Reliance Global Group(RELI.US)$ rose 9.51% to $6.68 in pre-market trading. Reliance Global Group, last month, announced pricing of $20.0 million private placement with institutional investors.
$Ocugen(OCGN.US)$ rose 8.62% to $4.41 in pre-market trading. Ocugen announced partner Bharat Biotech's COVAXIN booster dose study demonstrated robust immune responses and long-term safety.
$ShockWave Medical(SWAV.US)$ rose 6.50% to $180 in pre-market trading after declining around 5% on Friday.
$Fangdd Network(DUO.US)$ rose 6.45% to $0.396 in pre-market trading. FangDD, on Friday, received Nasdaq notice regarding minimum bid requirements.
Losers
$ATA Creativity Global(AACG.US)$ fell 9.47% to $2.39 in pre-market trading after jumping more than 33% on Friday.
$Marin Software(MRIN.US)$ fell 9.05% to $4.12 in pre-market trading. Marin Software shares jumped 31% on Friday after the company announced an integration with Amazon Ads' demand-side platform.
$Koss Corp(KOSS.US)$ shares fell 5.7% to $10.01 in pre-market trading.
$Arcadia Biosciences(RKDA.US)$ shares fell 5.3% to $1.08 in pre-market trading after climbing around 12% on Friday.
Comment(1)
Reason For Report